Journals / Medical Network Klinik Bilimler ve Doktor / 2000 / Cilt: 6 - Sayı: 4

Long term follow-up and investigation of hepatitis B and hepatitis C in children exchange transfused during neonatal period

Yenidoğan döneminde kan değişimi yapılan çocukların takibi ile hepatit B ve hepatit C taraması

Pages
482–486
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Effective screening of donor bloods will decrease the risk of post-transfusion hepatitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: In this study long-term follow-up of babies who were applied exchange transfusion and evaluation of risks of hyperbilirubinemia and exchange transfusion were aimed.
📊
Key Findings & Data:RESULTS: Mean follow-up time of pattern was 3.5±1.7 year.
💡
Conclusion & Impact:Effective screening of donor bloods will decrease the risk of post-transfusion hepatitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hepatit B · Risk · Hiperbilüribinemi

Abstract

AIM: In this study long-term follow-up of babies who were applied exchange transfusion and evaluation of risks of hyperbilirubinemia and exchange transfusion were aimed. METHODS: Forty-nine babies who applied exchange transfusion due to indrect hyperbilirubinemia were recruited, for the study. Physical and neurologic examination of patients were done. Blood counts, liver function tests, markers for hepatitis B and C of patients were investigated. RESULTS: Mean follow-up time of pattern was 3.5±1.7 year. The most encountered cause of exchange transfusion was ABO blood goup incompatibility (%51), second was Rh incompatibility (%10.2). Five patients have neurologic problems. %14.3 of them have iron deficiency anemia. Growth parameters of patients were not different from control group. Anti-HCV andHbsAg were found negative for all patients. CONCLUSION: With long-term follow-up, It is possible to determine the effects of indirect hyperbilirubinemia and exchange transfusion. Effective screening of donor bloods will decrease the risk of post-transfusion hepatitis.

Özet

AMAÇ: Bu çalışmada hiperbilirubinemi-nedeni ile kan değişimi yapılan çocukların uzun dönem takipleri ile hiperbilinıbineminin ve kan değişiminin risklerinin değerlendirmesi amaçlandı. YÖNTEM: İndirekt hiperbilirubinemi tanışı ile kan değişimi uygulanan 49 vaka çalışmaya alındı. Olguların fizik ve nörolojik muayeneleri yapıldı. Hemogrâm, karaciğer fonksiyon testleri, hepatit B ve C'ye ait belirleyicileri araştırıldı. BULGULAR: Hastaların ortalama takip süresi 3,5 ± 1,7. yıldı. En sık karşılaşılan kan değişimi nedeni ABO uyuşmazlığı (% 51), takiben Rh uyuşmazlığı (% 10,2) idi. Beş olguda (%10,2) nörolojik sorun saptandı. % 14,3 oranında demir eksikliği anemisi saptandı. Büyüme parametreleri kontrol grubundan farklı değildi. Tüm vakalarda anti-HCV ve HBs-Ag negatif bulundu. SONUÇ: Uzun dönem takipler ile indirekt hiperbilinıbineminin ve kan değişimine ait komplikasyonların etkilerinin tesbiti mümkündür. Donör kanlarında yapılan etkin taramalar post-transfiizyon hepatit gelişme riskini azaltacaktır.

🔖

Cite This Article

TUTULMAZ, Z., ŞIKLAR, Z., DALLAR, Y., TANYER, G., ÖZKAN, B. (2000). Long term follow-up and investigation of hepatitis B and hepatitis C in children exchange transfused during neonatal period. Medical Network Klinik Bilimler ve Doktor, Cilt: 6 - Sayı: 4, 482–486. https://ajindex.com/articles/279217

References (7)

  1. Maisels MJ. Jaundice In: Avery GB, Fletcher MA, Macdonald MG.(eds): Neonatology, Philadelphia: J. B. Lippincott Company, 1994; 630-725
  2. American Academy of Pediatrics, Hepatitis C virus infection, Committee on Infectious Diseases, Pediatrics, 1998; 101: 481-5
  3. Bolistreri WF, Rej R. Determination of Total and Conjugated Bilirubin in Serum, Liver Function In: Burtis C A, Ashwood ER.(eds): Tietz Textbook of Clinical Chemistry, Philadelphia, WB. Saunders Company, 1994; 1466-1468
  4. Fanaroff AA, Martin RJ. Jaundice and Liver Disease In: Neonatal-Perinatal Medicine, St. Louis USA, Mosby Year Book, 1992; 1075-1100
  5. Neyzi O, Gunöz H. Büyüme ve Gelişme Bozuklukları, Neyzi O, Ertuğml T.(editör): Pediatri Cilt 1, İstanbul, Nobel Tıp Kitabevi, 1993; 247-67 6. Gourley GR. Bilirubin metabolism and kernicterus, Adv Pediatr, 1997; 44:173-229
  6. Mailsels MJ, Newman TR. Kernicterus in Otherwise Healthy, Breast-fed Term Newborns, Pediatrics, 1995; 96: 730-3
  7. Sato M, Imashioya H, Tomoyoshi E, Torii S. Long-term follow-up of neonatal hyperbilirubinemia when phototherapy was withheld because of low bilirubin levels in the spinal fluid-growth, intelligence and soft neurological signs in school children, No To Hattatsu, 1991; 23(6): 541-7 9. American Academy of Pediatrics. Management of Hyperbilirubinemia in the Healthy Term Newborn. Pediatrics, 1994; 94:4. 10.Ünlüoğlu İ, Dallar Y, Tanyer G. Yurdumuzda Yayınlanan Yenidoğan Sarılığı İle İlgili Genel Çalışmaların Değerlendirilmesi. Sağlık ve Sosyal Yardım Vakfı Dergisi, 1996; 44-51. 11.Bor M, Zeben T, Vanhorick SP, Brand R, Ruys JH. Hyperbilirubinemia in Preterm Infants and Neurodevelopmental Outcome at Two Years of Ages Paediatrics, 1989; 6: 915-920. 12.Özmert E, Erdem G, Topçu M, Yurdakök M, Tekinalp G, Genç D, Renda Y. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants, Acta Paediatr, 1996; 85(12): 1440-4. 13.Hizel S, Tanyer G, Serdaroğlu A, Dallar Y, Genç D. Kan Değişimi Uygulanmış Hiperbilirubinemili Bebeklerin Uzun Dönem Risk Faktörleri Yönünden İzlenmesi, T Klin Pediatr, 1998;7:159-165 14.Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, Mc Allister HA. Reitz BA, Nelson KE. The Declining Risk of Post-Transfusion Hepatitis C Virus Infection, The New Eng J Med, 1992; 327:6, 369-373. 15.Callahan WE. The Risk Of Transfusion-Transmitted Infection, The New Eng J Med, 1992; 327:6,419-421. 16.Bortolotti F, Faggion S, Con P. Natural history of chronic viral hepatitis in childhood. Acta G